News Celanese Corporation

Equities

CE

US1508701034

We are working hard...

We are working hard to come back as soon as possible.
Nous travaillons dur pour revenir au plus vite.
Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
Estamos trabajando duro para volver lo antes posible.
Stiamo lavorando sodo per tornare il prima possibile.
Wij werken hard om zo snel mogelijk weer terug te zijn.

Apr. 17	Celanese Keeps Quarterly Dividend at $0.70 a Share, Payable May 13 to Stockholders of Record April 29	MT
Apr. 17	Celanese Corporation Declares Quarterly Dividend, Payable on May 13, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Celanese to Hold First Quarter Earnings Conference Call on May 9, 2024	Apr. 18	BU
Celanese Keeps Quarterly Dividend at $0.70 a Share, Payable May 13 to Stockholders of Record April 29	Apr. 17	MT
Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share	Apr. 17	BU
Celanese Corporation Declares Quarterly Dividend, Payable on May 13, 2024	Apr. 17	CI
Chemical Marketing & Economics Honors Celanese Chairman, CEO and President Lori J. Ryerkerk with STEM Leadership Award for Corporate Reinvention	Apr. 16	BU
BofA Securities Raises Price Target on Celanese to $145 From $135, Maintains Underperform Rating	Apr. 10	MT
KeyBanc Raises Price Target on Celanese to $190 From $176, Keeps Overweight Rating	Apr. 09	MT
Celanese Completes Series of Strategic Actions Across its Global Acetyl Chain	Apr. 09	BU
UBS Raises Celanese's Price Target to $199 From $175, Maintains Buy Rating	Apr. 08	MT
North American Morning Briefing : Investors on -2-	Apr. 05	DJ
JPMorgan Downgrades Celanese to Underweight From Neutral, Raises Price Target to $160 From $135	Apr. 04	MT
ANALYST RECOMMENDATIONS : Block, Chubb, Doordash, Coinbase, Lloyds...	Apr. 04
Wells Fargo Raises Price Target on Celanese to $195 From $180, Maintains Overweight Rating	Mar. 22	MT
Celanese Achieves ISCC CFC Certification for Low Carbon CCU Methanol	Mar. 21	BU
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies	Mar. 20	BU
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies	Mar. 20	CI
William M. Brown Announces Not Stand for Re-Election to the Board of Celanese Corporation	Mar. 14	CI
Celanese Announces Commercial Launch of Glaukos' iDose TR (Travoprost Intracameral Implant) using Celanese's VitalDose Ethylene Vinyl Acetate (EVA)	Mar. 01	AQ
Just as expected	Feb. 29
Celanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA)	Feb. 29	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

We are working hard...

We are working hard to come back as soon as possible.
Nous travaillons dur pour revenir au plus vite.
Wir arbeiten hart daran, so schnell wie möglich zurückzukommen
Estamos trabajando duro para volver lo antes posible.
Stiamo lavorando sodo per tornare il prima possibile.
Wij werken hard om zo snel mogelijk weer terug te zijn.